Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Welcome to the Lung Cancer Sessions with the Video Journal of Oncology (VJOncology).
Watch our expert roundtable discussions to learn about the latest advances in lung cancer research from the 2025 American Society of Clinical Oncology (ASCO) Meeting and what the data means for clinical practice.
Welcome to The Lung Cancer Sessions brought to you by the Video Journal of Oncology (VJOncology).
This exclusive roundtable discussion features leading experts João Alessi, MD, and Alessandro Di Federico, MD, Dana-Farber Cancer Institute, Boston, MA, who discuss key findings in lung cancer management from ASCO 2025.
Topics discussed include the practice-changing results of the DeLLphi-304 trial showing tarlatamab’s impressive efficacy in second-line small cell lung cancer, promising results from the OptiTROP-Lung03 trial testing sacituzumab tirumotecan for EGFR-mutant non-small cell lung cancer patients, and more.
